Growth Metrics

Cytosorbents (CTSO) Net Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 54.21%
Dec 31, 2025 -4.60%
Sep 30, 2025 -53.69%
Jun 30, 2025 -149.46%
Mar 31, 2025 244.39%
Dec 31, 2024 19.68%
Sep 30, 2024 -158.13%
Jun 30, 2024 189.02%
Mar 31, 2024 -197.55%
Dec 31, 2023 217.68%
Sep 30, 2023 17.85%
Jun 30, 2023 -88.68%
Mar 31, 2023 -468.59%
Dec 31, 2022 92.67%
Sep 30, 2022 41.44%
Jun 30, 2022 -41.27%
Mar 31, 2022 -24.32%
Dec 31, 2021 -58.84%
Sep 30, 2021 -57.77%
Jun 30, 2021 -0.59%
Mar 31, 2021 82.55%
Dec 31, 2020 -131.26%
Sep 30, 2020 507.46%
Jun 30, 2020 -38.76%
Mar 31, 2020 477.23%
Dec 31, 2019 -1,137.63%
Sep 30, 2019 90.91%
Jun 30, 2019 -23.22%
Mar 31, 2019 -5.95%
Dec 31, 2018 -643.18%
Sep 30, 2018 -108.11%
Jun 30, 2018 12.50%
Mar 31, 2018 96.59%
Dec 31, 2017 285.46%
Sep 30, 2017 -107.88%
Jun 30, 2017 751.60%
Mar 31, 2017 -79.02%
Dec 31, 2016 51.22%
Sep 30, 2016 -146.12%
Jun 30, 2016 405.03%
Mar 31, 2016 21.90%
Dec 31, 2015 -229.48%
Sep 30, 2015 74.34%
Jun 30, 2015 -135.87%
Mar 31, 2015 109.79%
Dec 31, 2014 172.25%
Sep 30, 2014 -195.93%
Jun 30, 2014 -136.43%
Mar 31, 2014 4,980.07%
Dec 31, 2013 -119.75%
Sep 30, 2013 -13.23%
Jun 30, 2013 239.97%
Mar 31, 2013 -13.32%
Dec 31, 2012 -199.95%
Sep 30, 2012 621.64%
Jun 30, 2012 -109.93%
Mar 31, 2012 155.56%
Dec 31, 2011 0.97%
Sep 30, 2011 -211.10%
Jun 30, 2011 -26.97%
Mar 31, 2011 364.22%
Dec 31, 2010 82.82%